CD34+ cells hold significant promise in regenerative medicine and the treatment of various vascular degenerative diseases primarily because of their ability to regenerate and differentiate into various cell types. These cells can be derived from embryonic stem cells (ESCs), induced pluripotent stem cells (iPSCs), or adult stem cells like blood and bone marrow, and can differentiate into endothelial, hematopoietic, myeloid, and other cell types. However, their characteristics vary based on the source, making detailed definitions essential for specific therapeutic applications. In this study, it was aimed to compare these two different CD34-positive cell populations by full genome transcriptional profiling (RNAseq). To this end, we first optimized a CD34+ cell differentiation protocol and found that Vascular Endothelial Growth Factor (VEGF) is critical for the transition of cells from mesodermal precursors to CD34+ cells. Additionally, principal component analysis (PCA) of RNAseq data showed that blood-derived CD34+ cells clustered far from iPS-derived CD34+ cells which illustrates these populations are fundamentally different. This data will be useful to better define these cell populations and facilitate the translation of regenerative approaches in this field as well as providing potentially novel diagnostic tools.
Keywords:
Published on: Mar 30, 2024 Pages: 1-13
Full Text PDF
Full Text HTML
DOI: 10.17352/jbm.000041
CrossMark
Publons
Harvard Library HOLLIS
Search IT
Semantic Scholar
Get Citation
Base Search
Scilit
OAI-PMH
ResearchGate
Academic Microsoft
GrowKudos
Universite de Paris
UW Libraries
SJSU King Library
SJSU King Library
NUS Library
McGill
DET KGL BIBLiOTEK
JCU Discovery
Universidad De Lima
WorldCat
VU on WorldCat
PTZ: We're glad you're here. Please click "create a new query" if you are a new visitor to our website and need further information from us.
If you are already a member of our network and need to keep track of any developments regarding a question you have already submitted, click "take me to my Query."